Showing results (11-20 of 941) with videos related to

Sort By:
Pageof 95
Transplantation|October 8, 2005
Cyclosporine formulation and Kaposi's sarcoma after renal transplantationDario Cattaneo, Eliana Gotti, Norberto Perico, et al.
Journal of Clinical Pharmacology|June 4, 2009
Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimenDario Cattaneo, Monica Cortinovis, Sara Baldelli, et al.
Internal and Emergency Medicine|March 18, 2016
Prevention programs for chronic kidney disease in low-income countriesNorberto Perico, Giuseppe Remuzzi
Current Opinion in Nephrology and Hypertension|December 26, 2001
Routine renin-angiotensin system blockade in renal transplantation?Giuseppe Remuzzi, Norberto Perico
Annals of Nutrition & Metabolism|June 20, 2015
Acute Kidney Injury in Poor Countries Should No Longer Be a Death Sentence: The ISN '0 by 25' ProjectNorberto Perico, Giuseppe Remuzzi
Clinical Nephrology|March 1, 2015
Need for chronic kidney disease prevention programs in disadvantaged populationsNorberto Perico, Giuseppe Remuzzi
Clinical Journal of the American Society of Nephrology : CJASN|October 12, 2007
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipientsDario Cattaneo, Monica Cortinovis, Sara Baldelli, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 25, 2005
High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimusSara Baldelli, Stefano Murgia, Simona Merlini, et al.
Therapeutic Drug Monitoring|October 14, 2006
Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipientsDario Cattaneo, Simona Merlini, Sara Baldelli, et al.
Nephron|September 20, 2016
Should We Still Believe in Randomized Controlled Trials in Nephrology?Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
Pageof 95